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Abstract
Midbrain dopaminergic neurons are involved in control of emotion, motivation and motor
behavior. The loss of one of the subpopulations, substantia nigra pars compacta, is the pathological
hallmark of one of the most prominent neurological disorders, Parkinson's disease. Several groups
have looked at the molecular identity of midbrain dopaminergic neurons and have suggested the
gene expression profile of these neurons. Here, after determining the efficiency of each screen, we
provide a linked database of the genes, expressed in this neuronal population, by combining and
comparing the results of six previous studies and verification of expression of each gene in
dopaminergic neurons, using the collection of in situ hybridization in the Allen Brain Atlas.
Background
The population of dopaminergic (DA) neurons in the
ventral midbrain is divided into three distinct groups,
substantia nigra pars compacta (SNpc) or the A9 group,
ventral tegmental area (VTA) or the A10 group, and retro-
rubral field. The A9 and A10 groups are the main source
of dopamine in the central nervous system and give rise to
two major dopaminergic pathways. Neurons of the VTA
innervate the nucleus accumbens and olfactory tubercle,
comprising the mesolimbic and mesocortical pathways,
and the target for SNpc innervation is the dorsal striatum,
thereby constituting the nigrostriatal pathway [1]. These
three pathways are involved in control of emotion, moti-
vation and motor behavior and are connected to neuro-
logical conditions such as addiction, schizophrenia and to
the second most common neurodegenerative disorder,
Parkinson's disease (PD) [2,3]. The main pathological
characteristic of PD is the progressive degeneration of DA
neurons in the SNpc. The functional and pathological rel-
evance of the neurons in SNpc and VTA necessitates in
depth study of their gene expression profile. In recent
years, several such studies have been carried out to iden-
tify the genes, expressed in these neuronal populations [4-
9].
Allen Brain Atlas (ABA) is a large-scale collection of gene
expression patterns, using high throughput, semi-auto-
mated in situ hybridization (ISH) on mouse brain sec-
tions. The expression patterns of over 21,000 genes have
been uploaded so far. Taking a genomic style approach,
ABA shows above background expression, in different
regions of the brain, for approximately 80% of the genes.
The ISH data is searchable either by anatomical structure
or using a finer (100–300 μm) resolution geometric grid
[10]. The data is also available as three dimensional
images and graphs, through the usage of a web browser
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and Brain Explorer. Another function of ABA, Neuroblast,
allows identification of genes with similar expression pat-
terns within the ABA dataset [11]. In this study, we have
combined/compared results of the six studies, aiming at a
comprehensive expression profile of mesDA neurons, and
verified the expression of the identified genes, using the
digital atlas made publicly accessible by the ABA. Here, we
present a database of this verification effort.
Results
Previously, six studies have analyzed the expression pro-
file of ventral midbrain cells or mesDA neurons, specifi-
cally, resulting in a list of several hundred genes [4-9].
Three of the studies were differential display based, which
studied the expression profile of the midbrain tissue in
mice. The other three studies used a more specific
approach and identified the global expression profile of
dopaminergic neurons of the subpopulations of mesDA
neurons in rats, using microarray. In order to combine the
lists of genes from the six studies, as a first step, we deter-
mined the association of sequences in the cDNA differen-
tial display-based studies (Stewart et al., Barrett et al. and
Thuret et al.) to genes and published ESTs, by checking
location of each hit on the mouse genome on Map Viewer
http://www.ncbi.nlm.nih.gov/mapview/ and by perform-
ing BLAST search. Among 1435 cDNA fragments, 1050
were unambiguous murine genomic hits, 19 were ambig-
uous multiple hits and 104 were alignments with mito-
chondrial DNA. 262 cDNA sequences produced no
significant alignments. Then, in order to compare all six
studies and make a comprehensive list, we determined the
mouse accession numbers of the genes from Chung et al.,
Greene et al. and Grimm et al. by performing BLAST
searches at http://www.ncbi.nlm.nih.gov/BLAST/. From
all the genes, presented in these screens, only the acces-
sion numbers of three genes were unidentifiable. A com-
parison of the six screens [4-9], and elimination of the
redundancies of genes, common to two or more studies,
resulted in a total of 609 genes.
In order to determine whether the genes, presented in
these screens, are present in VTA and/or SNpc, we looked
for above-background cellular expression in the ventral
midbrain, using Allen's Brain Atlas ISH database at http:/
/www.brain-map.org. As a control, the expression pattern
of the rate-limiting enzyme in production of dopamine,
tyrosine hydroxylase (Th) [12], in coronal and sagittal sec-
tions was used. Among 609 genes, 335 (56%) showed
strong expression in the SNpc or VTA (see Additional file
1). The efficiency of each screen, in identifying mesDA-
specific genes was 25% for Chung et al., 29% for Barrett et
al., 28% for Stewart et al., 37% for Greene et al., 24% for
Thuret et al. and 24% for Grimm et al. (see Additional file
2), which is an indication for the complementary nature
of the six screens. The final list of genes is presented in a
database, linked to the ISH images of ABA (database avail-
able upon request).
The Neuroblast function in the ABA is used to identify
genes with common expression patterns in the brain or
within specific regions of the brain. We used this tool to
confirm our data and to determine its efficiency in identi-
fying the expression of genes, within mesDA neuronal
population. Therefore, first we performed Neuroblast to
identify the list of genes with expression patterns, similar
to dopaminergic neuron-specific genes, involved in the
neurotransmitter phenotype of the mesDA neurons or the
transcription factors, which are required for development,
survival and maintenance of dopaminergic neurons in
developing embryos as well as the adult organisms. Th
[12], dopamine transporter (Dat), which is responsible
for uptake of dopamine, vesicular monoamine trans-
porter 2 (VMAT2), responsible for transport of dopamine
into synaptic vesicles [13], Homeobox transcription fac-
tor, Engrailed-1 (En1), [14] and the forkhead transcrip-
tion factor (Foxa2), [15] which are required for long term
survival and maintenance of dopaminergic neurons were
chosen as the base genes for the Neuroblast search.
Expression of all five genes was observed in ABA coronal
or sagittal series and three dimensional visualizer (Figure
1). The Neuroblast search revealed 703 genes (see Addi-
tional file 3), with similar expression patterns to one or
more of the five above genes (Th, Vmat2, Dat, En1,
Foxa2), of which, 70 were among the genes, expressed in
mesDA neurons, according to the original six transcrip-
tome analysis studies (see Additional file 4).
Discussion
In this work we present a searchable database of genes,
expressed by mesDA neurons, based on the results of six
previous expression screens and the in situ hybridization
data presented in Allen Institute's brain atlas. The effi-
ciency of each individual screen does not exceed 37%, i.e.
a large number of the genes, suggested by differential dis-
play or microarray studies, does not show above back-
ground levels of expression, detectable by ISH. However,
the combination of results from all screens increases the
efficiency to 56%, indicating the complementary nature
of the studies.
The Neuroblast function in ABA may seem self-sufficient
in determining the expression profile of a cell population
within the brain, by use of the genes with high expression
level within that cell population as template, but our
study shows that a combination of studies such as the six,
mentioned in this work, are still essential. The Neuroblast
function is only partially effective, since less than 20% of
the genes, identified by our approach were among the list
of genes, compiled from five Neuroblast searches.Molecular Neurodegeneration 2009, 4:6 http://www.molecularneurodegeneration.com/content/4/1/6
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Conclusion
From comparison of six previously published data sets
and the in situ hybridization data, available at Allen Brain
Atlas, we conclude a comprehensive database of the gene
expression profile of midbrain dopaminergic neurons,
known up to date. This database provides a starting point
for further investigations in the field, attempting to iden-
tify the molecular cascades, which may result in degener-
ation of this neuronal population during the course of
Parkinson's disease.
Methods
All nucleotide sequences used in this study are publicly
available at: http://www.ncbi.nlm.nih.gov/entrez/
query.fcgi?db=Nucleotide. To determine whether the EST
sequences, presented by the cDNA differential display-
based data, i.e. Barrett et al. (779 sequences; accession
numbers: BE824469 to BE824504, BE824506 to
BE824519, BE824521 to BE824561, BE824563 to
BE824823, BE824825 to BE825045, BE825047 to
BE825132, CK338036 to CK338155), Stewart et al. (496
cDNA sequences; accession numbers: AA008736,
W33210 to W33212, W33214 to W33289, W35421 to
W35480, W36130 to W36269, W39787 to W40005,
W40007 to W40008, W40010 to W40023, W45732) and
Thuret et al. (159 sequences; accession numbers:
CO436137 to CO436293) were associated to any identi-
fied gene, we checked the sequences on the Map Viewer at
the NCBI website, at http://www.ncbi.nlm.nih.gov/
mapview/ and employed each nucleotide sequence for a
nucleotide-nucleotide BLAST (blastn) (basic local align-
ment search tool) on the non-redundant database http://
www.ncbi.nlm.nih.gov/BLAST/ and on the mouse
genome http://www.ncbi.nlm.nih.gov/genome/seq/
BlastGen/BlastGen.cgi?taxid=10090.
In order to homogenize, compare and contrast the data
among all six screens, the mouse accession numbers of the
genes from the three latter studies, Chung et al., Greene et
al. and Grimm et al., was obtained by using BLAST search.
Then, a comparison of the screens [4-7,9,16] and elimina-
tion of the genes, common to two or more studies was car-
ried out. In order to determine whether the genes,
presented in these screens, are expressed within VTA and/
or SNpc, we searched for above-background cellular
expression in the ventral midbrain, using the Allen Brain
Atlas at http://www.brain-map.org. We did not differenti-
ate between the two populations, because the coronal
images were not available for about a third of the genes.
Finally, the same method was used to determine the
expression of a randomly chosen set of 300 genes in the
midbrain.
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Expression pattern of known mesDA neuron-specific transcription factors and genes involved in dopamine neurotransmission  in mouse brain Figure 1
Expression pattern of known mesDA neuron-specific transcription factors and genes involved in dopamine 
neurotransmission in mouse brain. Three-dimensional view of Foxa2, En1, Th, Vmat2 (Slc18a2) and Dat (Slc6a3) expres-
sions in the brain, superimposed on a sagittal nissl image from Allen Brain Atlas (ABA) are shown. The genes chosen for Neu-
roblast search have known functions in the adult mesDA neurons and are detected by ABA in ventral midbrain (arrow).Publish with BioMed Central    and   every 
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Additional file 1
List of genes, expressed within dopaminergic neurons of the midbrain, 
according to ABA. The list of genes identified by the six screens (Chung 
et al., Barrett et al., Stewart et al., Greene et al., Thuret et al. and Grimm 
et al.), after eliminating the duplicates and triplicates, which showed 
expression patterns similar to tyrosine hydroxylase within ventral mid-
brain.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1750-
1326-4-6-S1.pdf]
Additional file 2
Number of genes, identified by six screens, aimed at determining the 
expression profile of mesDA neurons. Total number of genes, as well as 
the number of transcripts, expressed in SNpc or VTA, detectable by ISH, 
within the ABA database is shown. Efficiency of each screen in identifying 
transcripts, which show above-background expression within either or both 
of the two regions, according to ABA is between 24–38%, while 56% of 
the genes from combination of all screens show expression.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1750-
1326-4-6-S2.pdf]
Additional file 3
Compilation of gene symbols, identified by Neuroblast function of 
ABA. The template genes Foxa2, En1, Th, Vmat2 and Dat, used for neur-
blast, are expressed and have defined functions in neurotransmitter phe-
notype or transcriptional regulation of survival and maintenance of 
dopaminergic neurons. 250 genes were listed as having similar expression 
patterns to each template. Repetitions are eliminated from the final list.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1750-
1326-4-6-S3.pdf]
Additional file 4
Comparison of the list of genes from Neuroblast and genome-wide 
screens. The comparison of the two lists from additional files 1 &2 show 
that a fraction of the genes from the six screens, considered by this study 
can be acquired, using the Neuroblast function.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1750-
1326-4-6-S4.pdf]